Intellectual Property: Patent Litigation
Germany
11 years ranked
Provided by HOYNG ROKH MONEGIER
Patents
Christine Kanz has worked as an attorney since 1998. Although she has primarily focused on international patent litigation in the areas of pharmaceuticals, biotechnology and chemistry, she has also handled numerous cases in the areas of medical devices, mechanics and consumer products.
Much of her work involves cross-border litigation with the result that she is highly experienced in planning and coordinating such cases.
After attending the Max Planck Institute for Intellectual Property, Competition and Tax Law in Munich as an auditing student, she obtained her PhD in trademark law in 2002 at the University of Düsseldorf.
Christine regularly publishes on patent law matters and speaks at conferences on patent law issues. She is also a visiting lecturer at the Hagen Law School.
American Intellectual Property Law Association (AIPLA)
International Association for the Protection of Intellectual Property (AIPPI)
European Patent Lawyers Association (EPLAW)
German Association for the Protection of Intellectual Property (GRUR)
Intellectual Property Owners Association (IPO)
Licensing Executives Society (LES)
Association of Intellectual Property Experts (VPP)
Kanz/Gerhardt: What are the risks of second medical use and dosing regimes in pharmaceutical patenting?, Pharmaceutical Patent Analyst, Volume 3, Issue 5, September 2014, p. 481 ff.
Kanz/Lunze: Your Guide to IP issues in Germany, MIP IP Focus Life Sciences, 7th edition 2009, p. 48ff.
Kanz in: Drafting Agreements in the Biotechnology and Pharmaceuticals Industries, Oxford University Press, 2009
Kanz, in: Gewerblicher Rechtsschutz – Urheberrecht – Medienrecht, Kommentar, Carl Heymanns Verlag 2008 (Patentrecht, Mitautor)
Kanz (Mitautorin), Verfahrensrecht und Besonderheiten des Prozessrechts, Berlin Verlag 2007
Kanz, Recent developments in German jurisdiction regarding damages following patent infringement, Pharmaceutical Law Insight, October 2006, Vol. 2, Number 9, p. 17
Kanz/Kasper, Management of US Discovery in Continental Europe: A Practice Report from Germany in The IP Litigator, issue September/October 2005
Kanz, Schutz von Medizinprodukten durch technische Schutzrechte, in: Anhalt/Dieners, Handbuch des Medizinprodukterechts, 2003
Kanz, Zum Kennzeichenrecht im Internet, Düsseldorf 2002
Kanz, Haftungsrechtliche Aspekte von Fahrerassistenzsystemen, ZfAW 2002, 38 ff.
Kanz, How to Collect Evidence in Europe: Proceedings in Germany, Italy and France, and U.S. Discovery in Europe, BNA International, Vol. 20, number 1, p. 20.
Provided by Chambers
Christine Kanz boasts an impressive patent litigation practice that offers a broad range of deep expertise to consistently meets clients' needs. She is particularly popular with life sciences corporations, which she confidently represents in both claimant and defendant patent disputes.
Christine Kanz verfügt über eine beeindruckende Expertise im Patentrecht und bietet ihren Mandanten ein breites Spektrum an fundierten Fachkenntnissen, um deren Bedürfnisse stets zu erfüllen. Sie ist besonders bei Unternehmen der Biowissenschaften-Branche beliebt, die sie in Patentstreitigkeiten sowohl als Klägerin als auch als Beklagte souverän vertritt.
Provided by Chambers
Christine Kanz is just excellent. She's very experienced and professional, knows how to tackle disputes and provides us with precise advice.
Christine Kanz ist einfach hervorragend. Sie ist sehr erfahren und professionell, weiß, wie man Streitigkeiten beilegt und gibt uns präzise Ratschläge.
Chambers is the leading data and intelligence partner for the legal sector.